open access

Vol 74, No 2 (2023)
Original article
Submitted: 2023-05-03
Accepted: 2023-06-12
Published online: 2023-06-30
Get Citation

COVID-19 on board a cruise ship: medical management

Laurent Beust12, David Lucas13, Richard Pougnet14, Brice Loddé14
·
Pubmed: 37417840
·
IMH 2023;74(2):83-88.
Affiliations
  1. Société Française de Médecine Maritime, Brest, France
  2. Medical staff of Ponant Company 408, Marseille, France
  3. Service de santé des gens de mer, Brest, France
  4. Université de Bretagne Occidentale; Centre Régional de Pathologies Professionnelles et Environnementales, Brest, France

open access

Vol 74, No 2 (2023)
MARITIME MEDICINE Original article
Submitted: 2023-05-03
Accepted: 2023-06-12
Published online: 2023-06-30

Abstract

Background: First, this analysis was conducted to study a coronavirus disease 2019 (COVID-19) cluster
dynamic on a cruise ship in order to allow the ship physician to anticipate the duration and importance
of the contaminations. Secondly, the author tries to find out if the closed environment on board allows
specific conclusions about epidemic dynamics and preventative measures.
Materials and methods: From a personal epidemiological compendium done by himself on board the author
analysed different epidemic curves identified on board other ships and compared them to the epidemiologic
data from the different COVID-19 contamination waves in France since 2020. All crew members
were submitted to polymerase chain reaction tests on D2, D5, D8 and D15 and symptomatic cases were
tested on on-board devices in the meantime. An excel file called “Log Covid” allowed for daily reporting
to the ship-owner on the epidemic dynamics and the prospects on the end of crises in order to anticipate
the resumption of the business in the best conditions. The jobs on board, age and geographic origin
of the contaminated people were analysed, as well as their vaccination status.
Results: Out of a total of 118 crew members, 61 (52%) sailors were contaminated in 8 days. The symptoms
were benign (pharyngitis, headaches, feverish state); no serious form of illness were reported. The passengers
were repatriated to France at the earliest stage. The epidemic phase occurred in a 15-day window.
The first 8 days corresponded to the ascending phase, then a faster phase of epidemic decrease of 7 days.
Similarities emerged between the epidemic dynamics of this virus and other contaminations on cruise
ships and epidemic phases on land in spite of important differences in numbers.
Conclusions: This study can allow a ship’s doctor to better understand the viral dynamics in case of a COVID-
19 cluster and to anticipate the exit of the crisis. Repeated tests during the active phase of the epidemic
are necessary in case of a large cluster to know where to place oneself on a typical epidemic curve. Isolation
and barrier measures advised by the ship’s doctor remain the only weapons that can limit its magnitude.

Abstract

Background: First, this analysis was conducted to study a coronavirus disease 2019 (COVID-19) cluster
dynamic on a cruise ship in order to allow the ship physician to anticipate the duration and importance
of the contaminations. Secondly, the author tries to find out if the closed environment on board allows
specific conclusions about epidemic dynamics and preventative measures.
Materials and methods: From a personal epidemiological compendium done by himself on board the author
analysed different epidemic curves identified on board other ships and compared them to the epidemiologic
data from the different COVID-19 contamination waves in France since 2020. All crew members
were submitted to polymerase chain reaction tests on D2, D5, D8 and D15 and symptomatic cases were
tested on on-board devices in the meantime. An excel file called “Log Covid” allowed for daily reporting
to the ship-owner on the epidemic dynamics and the prospects on the end of crises in order to anticipate
the resumption of the business in the best conditions. The jobs on board, age and geographic origin
of the contaminated people were analysed, as well as their vaccination status.
Results: Out of a total of 118 crew members, 61 (52%) sailors were contaminated in 8 days. The symptoms
were benign (pharyngitis, headaches, feverish state); no serious form of illness were reported. The passengers
were repatriated to France at the earliest stage. The epidemic phase occurred in a 15-day window.
The first 8 days corresponded to the ascending phase, then a faster phase of epidemic decrease of 7 days.
Similarities emerged between the epidemic dynamics of this virus and other contaminations on cruise
ships and epidemic phases on land in spite of important differences in numbers.
Conclusions: This study can allow a ship’s doctor to better understand the viral dynamics in case of a COVID-
19 cluster and to anticipate the exit of the crisis. Repeated tests during the active phase of the epidemic
are necessary in case of a large cluster to know where to place oneself on a typical epidemic curve. Isolation
and barrier measures advised by the ship’s doctor remain the only weapons that can limit its magnitude.

Get Citation

Keywords

COVID-19, infection, maritime, boat

About this article
Title

COVID-19 on board a cruise ship: medical management

Journal

International Maritime Health

Issue

Vol 74, No 2 (2023)

Article type

Original article

Pages

83-88

Published online

2023-06-30

Page views

1331

Article views/downloads

425

DOI

10.5603/IMH.2023.0012

Pubmed

37417840

Bibliographic record

IMH 2023;74(2):83-88.

Keywords

COVID-19
infection
maritime
boat

Authors

Laurent Beust
David Lucas
Richard Pougnet
Brice Loddé

References (10)
  1. Kordsmeyer AC, Mojtahedzadeh N, Heidrich J, et al. Systematic review on outbreaks of SARS-COV-2 on cruise, navy and cargo ships. Int J Environ Res Public Health. 2021; 18(10): 5195.
  2. Rosca E, Heneghan C, Spencer E, et al. Transmission of SARS-COV-2 associated with cruise ship travel: a systematic review. Trop Med Infectious Disease. 2022; 7(10): 290.
  3. Codreanu TA, Ngeh S, Trewin A, et al. Successful control of an onboard COVID-19 outbreak using the cruise ship as a quarantine facility, Western Australia, Australia. Emerg Infect Dis. 2021; 27(5): 1279–1287.
  4. Chatard JC, Le Gac JM, Gonzalo S, et al. Management of COVID-19 on board the mixed cargo ship Aranui 5. Int Marit Health. 2021; 72(3): 155–162.
  5. Jimi H, Hashimoto G. Challenges of COVID-19 outbreak on the cruise ship Diamond Princess docked at Yokohama, Japan: a real-world story. Glob Health Med. 2020; 2(2): 63–65.
  6. Baraniuk C. What the Diamond Princess taught the world about COVID-19. BMJ. 2020; 369: m1632.
  7. Jégaden D, Dewitte JD, Loddé B. Maritime medicine in France. Int Marit Health. 2004; 55(1-4): 131–136.
  8. Ogden N, Fazil A, Arino J, et al. Scénarios de modélisation de l’épidémie de COVID-19 au Canada. Relevé des maladies transmissibles au Canada. 2020: 225–231.
  9. Davis JT, Chinazzi M, Perra N, et al. Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave. Nature. 2021; 600(7887): 127–132.
  10. Zhang Hu, Wang Q, Chen J, et al. Cruise tourism in the context of COVID-19: Dilemmas and solutions. Ocean Coast Manag. 2022; 228: 106321.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland

tel.: +48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl